In a pivotal trial of Science’s Prima BCI, 84% of patients impacted by dry AMD were able to read again once fitted with the technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results